Puberty Blocker Trial for Gender Questioning Children
Update: 2025-12-17
Description
Health Secretary Wes Streeting announces a trial of puberty blocking drugs for gender-questioning children, despite his previous ban. The trial, called PATHWAYS, aims to gather more robust evidence, but faces opposition from politicians and medical professionals concerned about potential harm. The trial is set to begin in January, involving around 226 participants, with close monitoring of their physical and mental health. Streeting emphasizes parental consent and openness to further evidence.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel





